Global Respiratory Drug Delivery Market | Growth, Trends, and Forecast 2016-2021

The market is witnessing growth due to factors such as increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers, and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis.

The respiratory drug delivery market is segmented based on formulations, canister type, applications, end users, and regions. The formulation segment is further divided into device type and formulation type.

The respiratory drug delivery market, by device type, is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The metered dose inhalers segment is expected to account for the largest share of the market by type of delivery by device, in 2016. Factors such as the efficient absorption of drugs through the lungs and negligible side effects (as drugs are exposed only to the lungs) are contributing to the growth of this segment.

Download PDF –

The respiratory drug delivery market, based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles.

Based on canister type, the respiratory drug delivery market is segmented into plain canisters and coated canisters. The plain canisters segment is expected to command the largest share of the pulmonary drug delivery devices market in 2016. The market for these canisters is majorly driven by the rising incidence of COPD and increasing use of inhalers

Based on end user, the respiratory drug delivery market is segmented into hospitals & clinics and home care settings. In 2016, the home care settings segment is expected to grow at a highest CAGR of the market due to technological advancements such as digital inhalers in pulmonary drug delivery devices that enable their usage in the home care settings.

Prominent players in the respiratory drug delivery market include GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.).

Know more about Respiratory Drug Delivery Market –